BioCardia, Inc.

BCDA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$7,946-$11,571-$11,907-$12,623
Dep. & Amort.$67$84$82$60
Deferred Tax$0$0$0$0
Stock-Based Comp.$741$1,030$1,183$1,661
Change in WC-$1,217$129-$214-$63
Other Non-Cash$329$354$295$599
Operating Cash Flow-$8,026-$9,974-$10,561-$10,366
Investing Activities
PP&E Inv.-$6-$12-$70-$116
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$6-$12-$70-$116
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$10,552$4,388$5,540$2,001
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1,252-$662-$418-$54
Financing Cash Flow$9,300$3,726$5,122$1,947
Forex Effect$0$0$0$0
Net Chg. in Cash$1,268-$6,260-$5,509-$8,535
Supplemental Information
Beg. Cash$1,103$7,363$12,872$21,407
End Cash$2,371$1,103$7,363$12,872
Free Cash Flow-$8,032-$9,986-$10,631-$10,482